GlobeImmune Inc (GBIM)
0.00
USD |
OTCM |
Apr 18, 16:00
GlobeImmune Total Liabilities (Quarterly): 7.621M for March 31, 2016
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2016 | 7.621M |
| December 31, 2015 | 8.518M |
| September 30, 2015 | 9.458M |
| June 30, 2015 | 10.70M |
| March 31, 2015 | 11.35M |
| December 31, 2014 | 12.76M |
| Date | Value |
|---|---|
| September 30, 2014 | 13.34M |
| June 30, 2014 | 224.52M |
| March 31, 2014 | 217.27M |
| December 31, 2013 | 206.74M |
| June 30, 2012 | 201.62M |
| March 31, 2012 | 200.75M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Ampio Pharmaceuticals Inc | 2.376M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.771M |
| Shareholders Equity (Quarterly) | 2.150M |